>630 articles dealing with the use of ANNs have been listed in
Medline, including several recent reviews with application to the clinical laboratory [1, 2] . Is the interest and enthusiasm warranted, or will this introduction mirror that of other diagnostic tests in medicine: initially promising performance followed by disappointment as the tool emerges from the research laboratory into practical use? In this issue of Clinical Chemistry, J#{248}orgensen et al. [3] and Pedersen et at. [4] or "stimulatory" of a particular outcome, the entire network of nodes is reminiscent of the way nerves act in the brain, hence the name.
A major downside introduced by "hidden nodes" has been the creation of a host of methodological problems and "inscrutability." The number and arrangement of the hidden nodes are a source of debate (and research), and only with the simplest of ANNs is it possible to discern how the nodes influence the ANN's decision-making in a way meaningful to humans. On first exposure, the ANN's ability to learn seems "magical" because of the hidden logic by which it makes its decisions. In the first article, J#{248}rgensen et al. [3] describe the process an ANN uses to learn to make a decision. They also address methodological issues by trying to determine how many cases are needed to train an ANN and how many internal hidden nodes are optimal. Their study is an observational one, in which they vary certain parameters, observe how well the ANN does after the change, and try to draw generalizations from these results. A strength of their approach is that they are careful to separate the performance of the ANNs on the training set used to construct it from its performance on an independent set of data after the model has been completed.
This appropriate distinction has sometimes been neglected in studies of mathematical decision aids. The authors also derive rules of thumb regarding the number of internal nodes to use, given a fixed set of input parameters.
However, generalizations regarding hidden nodes in ANNs are difficult, because the optimal number or even the desirability of hidden nodes depends on the clinical question being asked and the clinical data at hand. Separating hyperthyroid patients from euthyroid patients may be a more straightforward task than determining which patients in an intensive care unit will die tomorrow.
The heterogeneity of the second set of patients may require a much more complex model and hence more hidden nodes. Others have both theoretically [8] the operators can not know whether a more optimal solution is being missed.
An outstanding aspect of the first paper is its use of receiveroperating characteristic (ROC) curves to compare the performance of ANNs and discriminant analysis. ROC curves graphically display the true-positive rate vs the false-positive rate [9] . Although ROC curves are now accepted in the laboratory community as necessary for meaningful comparisons of different methodologies, only a subset of the ANN literature uses ROC curves as an evaluative strategy. It would be a mistake to assume that ANNs are different from any other laboratory test. Without an explicit examination of the tradeoff between sensitivity and specificity, the true performance of an ANN is impossible to evaluate.
In this paper [3] , using ROC analysis reveals the performance of the ANN to be superior to linear discriminant analysis but quite comparable with that of quadratic discriminant analysis.
In the second paper, Pedersen et al. [4] And finally, we must not let our enthusiasm for magic overshadow the knowledge that every test must be critically analyzed for its comparative strengths and weaknesses, and for its costs and benefits to the patient.
